United States Glaucoma Pharmaceuticals Markets

 

Regular Price: USD 2,450

Special Price USD 1,715

30% OFF

* Required Fields

Regular Price: USD 2,450

Special Price USD 1,715

PAY BY INVOICE

Be the first to review this product

Table of Contents

United States Glaucoma Pharmaceuticals Markets, Executive SummaryObjectives and PurposeObjectives and PurposeReport Structure and Market SegmentationReport Structure and Market SegmentationSummary of Major FindingsMarket Growth, Opportunities, and Total ForecastAnalysis by Major SegmentCompetitive AnalysisConclusionsUnited States Glaucoma Pharmaceuticals Markets, Research MethodologyPresentation of Market Engineering Measurements, Definition, and Strategic SignificancePresentation of Market Engineering Measurements, Definition, and Strategic SignificanceJudging Credibility and Accuracy of Market Engineering ForecastsGlossary of TermsList of AcronymsList of DefinitionsUnited States Glaucoma Pharmaceuticals Markets, Industry Challenges and OpportunitiesChallenges Facing the Glaucoma Drugs IndustryChallenges Facing the Glaucoma Drugs IndustryDrug Introductions Continue to Affect Market Dynamics, Threatening Existing Market LeadersShifting of Patients to New Classes of Drugs Demands Repositioning of Existing ProductsOvercoming Complex Nature of Treating Geriatric Patients Raises Patient Compliance IssuesCompeting with New Technologies for Interocular Pressure Control Threatens Pharmaceutical Glaucoma Drugs MarketPossible Development of Neuroprotective Drugs May Render Current Therapies ObsoleteDemand to Produce Better-Efficacy Drugs Shrinks MarginsBetter Understanding of Causes of Glaucoma May Alter Treatment PathwaysShrinking Product Life Cycle Threatens Product ProfitabilityThreats from New Legislation May Affect Market ProfitabilityKeeping Abreast of Market Developments Essential for SuccessIdentification of Opportunities Presented in the Glaucoma Drugs MarketIdentification of Opportunities Presented in the Glaucoma Drugs MarketMarket Engineering Research for the U.S. Glaucoma Drugs MarketMarket Overview and DefinitionsMarket DefinitionDisease OverviewChoosing Appropriate TreatmentProduct DefinitionsMarket Engineering Research Measurement SystemMarket Engineering Research Measurement SystemPatient Population AnalysisPatient Population AnalysisMarket Engineering and Revenue Forecasts (1994-2003)Market DriversMarket RestraintsPricing Strategy and Trend AnalysisMarket ForecastsOther Market and Technology TrendsTrends by Market SegmentTechnology TrendsCompetitive StructureMarket ParticipantsMarket Winners and WhyMarket Engineering Research for the U.S. Pilocarpine Drugs MarketMarket Overview and DefinitionsMarket OverviewProducts Included in the AnalysisMarket Engineering Research Measurement SystemMarket Engineering Research Measurement SystemMarket Engineering Revenue Forecasts (1994-2003)Demand AnalysisPricing Strategy and Trend AnalysisMarket DriversMarket RestraintsMarket ForecastsTechnology TrendsTechnology TrendsCompetitive StructureCompetitive StructureMarket Share TrendsMarket OpportunitiesProduct AnalysisProvider Prescribing PracticesMarket Engineering Research for the U.S. Adrenergic Agonist Drugs MarketMarket Overview and DefinitionsMarket OverviewProducts Included in the AnalysisMarket Engineering Research Measurement SystemMarket Engineering Research Measurement SystemMarket Engineering Revenue Forecasts (1994-2003)Demand AnalysisPricing Strategy and Trend AnalysisMarket DriversMarket RestraintsMarket ForecastsCompetitive StructureCompetitive StructureMarket Share Trends Market Opportunities and StrategiesProduct AnalysisProvider Prescribing PracticesMarket Engineering Research for the U.S. Beta-Blocking Drugs MarketMarket Overview and DefinitionsMarket Overview Products Included in the AnalysisMarket Engineering Research Measurement SystemMarket Engineering Research Measurement SystemMarket Engineering Revenue Forecasts (1994-2003)Demand AnalysisPricing Strategy and Trend AnalysisMarket DriversMarket RestraintsMarket ForecastsCompetitive StructureCompetitive StructureMarket Share Trends Market Opportunities and StrategiesProduct AnalysisProvider Prescribing PracticesMarket Engineering Research for the U.S. Carbonic Anhydrase Inhibitor Drugs MarketMarket Overview and DefinitionsMarket OverviewProducts Included in the AnalysisMarket Engineering Research Measurement SystemMarket Engineering Research Measurement SystemMarket Engineering Revenue Forecasts (1994-2003)Demand AnalysisPricing Strategy and Trend AnalysisMarket DriversMarket RestraintsMarket ForecastsCompetitive StructureCompetitive StructureMarket Share Trends Market Opportunities and StrategiesProduct AnalysisProvider Prescribing PracticesMarket Engineering Research for the U.S. Prostaglandin Analogue Drugs MarketMarket Overview and DefinitionsMarket OverviewProducts Included in the AnalysisMarket Engineering Research Measurement SystemMarket Engineering Research Measurement SystemMarket Engineering Revenue Forecasts (1994-2003)Demand AnalysisPricing Strategy and Trend AnalysisMarket DriversMarket RestraintsMarket ForecastsCompetitive StructureCompetitive StructureMarket Share Trends Product AnalysisProvider Prescribing PracticesThe Role of Market Engineering in the Pharmaceutical BusinessIntegrating Market Engineering into Business PlanningIntegrating Market Engineering into Business PlanningCurrent Company Status LocationDesired StatusDeveloping the StrategyImplementing the StrategyUsing Market Engineering to Address Industry Challenges, Market Trends, and OpportunitiesUsing Market Engineering to Address Industry Challenges, Market Trends, and OpportunitiesImplementation of Market Engineering in the Corporate StructureImplementation of Market Engineering in the Corporate StructureHow to Implement Market Engineering in a CompanyHow to Make the Most of this Marketing Engineering ReportThe Ten Top Ways To Maximize the Value of this ReportMarket Engineering Monitoring of the Pharmaceutical IndustryThe Purpose of Market Engineering MonitoringHow to Design a Successful Monitoring ProgramFrost & Sullivan Strategic Recommendations for Further Research




Keyword1

Keyword2

Keyword3

Related Research

Release Date : 21-Nov-17

Region : North America

Release Date : 20-Nov-17

Region : North America

Release Date : 20-Nov-17

Region : North America

Why Frost & Sullivan

Working with the CEO’s growth team to create a vision based on a transformation growth strategy

Creating content-based digital marketing strategies that leverage our research perspective to differentiate and “tell your story”

Tracking over 1000 emerging technologies and analyzing the impact by industry and application to reveal the companies to watch in each sector

The Frost & Sullivan team is based in our 45 global offices and have developed a powerful global understandings of how industries operate on a global level.